- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
111 Bl.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Ulm, Univ., Diss., 2013
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Faber, Katrin
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Faber, Katrin
Ähnliche Objekte (12)
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Identification and characterization of a Y chromosome-encoded gene overexpressed in acute myeloid leukaemia cells
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Proteome-wide identification of new molecular targets affected by methotrexate in acute promyelocytic leukaemia cell line
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Targeting acute myeloid leukaemia with the small molecule inhibitors of the Myb/p300 interaction
Characterisation of hypomethylating agent/IAP antagonist-induced cell death in acute myeloid leukaemia cells
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Identification and characterization of a Y chromosome-encoded gene overexpressed in acute myeloid leukaemia cells
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Proteome-wide identification of new molecular targets affected by methotrexate in acute promyelocytic leukaemia cell line
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Targeting acute myeloid leukaemia with the small molecule inhibitors of the Myb/p300 interaction
Characterisation of hypomethylating agent/IAP antagonist-induced cell death in acute myeloid leukaemia cells
Survivin’ acute Myeloid Leukaemia : a personalised target for inv(16) patients
Identification and characterization of a Y chromosome-encoded gene overexpressed in acute myeloid leukaemia cells
Loss of heterozygosity in acute myeloid leukaemia with normal karyotype
Detection of DNMT3A R882 mutations in patients with acute myeloid leukaemia
Characterization of the role of the CDX2 homeodomain in acute myeloid leukaemia
Proteome-wide identification of new molecular targets affected by methotrexate in acute promyelocytic leukaemia cell line
Functional characterisation of Enhancer of Zeste-Homologue 2 (EZH2) in acute myeloid leukaemia
Differences between intrinsic and acquired nucleoside analogue resistance in acute myeloid leukaemia cells
Targeted siRNA carrier systems for the treatment of acute myeloid leukaemia (AML)
Single cell metabolic multiomics to identify vulnerabilities in acute myeloid leukaemia stem cells
Targeting acute myeloid leukaemia with the small molecule inhibitors of the Myb/p300 interaction